News

November 20, 2019November 20, 2019

$1.34M Grant Will Be Used to Broaden Psychosocial Research into Dementia Care

News

The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance care and support for those with Alzheimer’s disease (AD) or other ... Read more

November 19, 2019November 19, 2019

UW Scientist Awarded $17.2M Grant to Study Link Between Eye Health and Alzheimer’s

News

A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National Institute on Aging (NIA) grant to study whether degenerative eye diseases ... Read more

November 18, 2019November 18, 2019

Antioxidant Compound, with Aid of Baker’s Yeast, May Offer Oral Supplement to Offset Alzheimer’s

News

A natural compound with antioxidative properties that might help to delay the onset of neurodegenerative diseases like Alzheimer’s can now be produced in baker’s yeast, a study reports. This ... Read more

November 15, 2019November 15, 2019

Humana and Seniorlink Offering Tech-Enabled Coaching to Dementia Caregivers

News

Expanding their existing relationship, Seniorlink and Humana are offering a program that provides additional care management and support to families caring for individuals with dementia, including Alzheimer’s disease. The dementia management ... Read more

November 13, 2019November 13, 2019

Study into Way of Detecting Alzheimer’s via Eye Scans Goal of Optina Diagnostics, Wagner Center Partnership

News

Laying the foundation for what could be a pivotal clinical trial into Alzheimer’s (AD) detection, Optina Diagnostics and Wagner Macula & Retina Center will collaborate on a “real-world” study aimed at ... Read more

November 12, 2019November 12, 2019

Neflamapimod Fails to Improve Memory But Shows Impact on Tau Levels in Phase 2b Study, EIP Pharma Announces

News

A Phase 2b study of oral neflamapimod in treating mild Alzheimer’s disease met its secondary goals of statistically significant drops in phospho-tau and tau protein levels in the cerebrospinal fluid (CSF) ... Read more

November 8, 2019November 8, 2019

Vaccine Decreases Tau Tangles, Improves Memory and Motor Function in Mouse Model of Alzheimer’s, Study Says

News

An experimental vaccine targeting the toxic form of tau protein reduced cellular tangles in the brain — a hallmark of Alzheimer’s — and eased behavioral and motor defects in ... Read more

November 6, 2019November 6, 2019

$15M Investment Helps Secure Funding for Phase 2 Trial of T3D-959 for Alzheimer’s

News

T3D Therapeutics has secured the needed funding to move forward with its Phase 2 trial testing T3D-959 as a potential treatment for people with mild-to-moderate Alzheimer’s disease. The total ... Read more

November 5, 2019November 5, 2019

Alzheimer’s Awareness Month in US Focuses on Caregivers, Resources and Education

News

Efforts are underway this month to focus attention on Alzheimer’s (AD), a disease that, along with other forms of dementia, affects some 44 million people globally and is rapidly growing ... Read more

November 5, 2019November 5, 2019

Seaweed-based Therapy Approved in China for Mild to Moderate Alzheimer’s, 1st New Treatment in 16 Years

News

Oligomannate (GV-971), a compound derived from marine brown algae that promotes a healthy gut microbiome, is now conditionally approved in China to treat mild to moderate Alzheimer’s disease (AD), ... Read more

Pin It on Pinterest